Inventor · disambiguated record
Christine Wurth
Also filed as: WURTH CHRISTINE
4 granted patents·9 pending applications·21 citations·filing 2006–2024
72Inventor score
Top patents by PatentIndex Score
13 records- 0193US11654105B2Subcutaneous HER2 antibody formulationsGENENTECH INC·Filed 2022·Granted May 23, 2023·7 cites·30 claims
- 0292US10849849B2Subcutaneous HER2 antibody formulationsGENENTECH INC·Filed 2018·Granted Dec 1, 2020·13 cites·28 claims
- 0379US10925966B2Antibody formulationsGENENTECH INC·Filed 2017·Granted Feb 23, 2021·1 cites·35 claims
- 0479US2024269064A1Subcutaneous her2 antibody formulationsGENENTECH INC·Filed 2024·Application pending·0 cites
- 0566US2021085597A1Subcutaneous her2 antibody formulationsGENENTECH INC·Filed 2020·Application pending·0 cites
- 0656US2009162352A1Antibody formulationADLER MICHAEL·Filed 2008·Application pending·0 cites
- 0754US12503503B2Bispecific anti-VEGF/ANG2 antibody formulationHOFFMANN LA ROCHE·Filed 2021·Granted Dec 23, 2025·0 cites·13 claims
- 0850US2015353640A1Antibody formulationHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 0949US2010098712A1Pharmaceutical formulation of an antibody against OX40LADLER MICHAEL·Filed 2009·Application pending·0 cites
- 1049US2009208509A1Pharmaceutical formulation of an antibody against IL-1RROCHE PALO ALTO LLC·Filed 2008·Application pending·0 cites
- 1139US2007077552A1High throughput screen for inhibitors of polypeptide aggregationHECHT MICHAEL·Filed 2006·Application pending·0 cites
- 1238US2011070225A1Beta antibody parenteral formulationGOLDBACH PIERRE·Filed 2007·Application pending·0 cites
- 1335US2012128687A1Novel antibody formulationADLER MICHAEL·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christine Wurth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →